SRDX — SurModics Income Statement
0.000.00%
Last trade - 00:00- $421.10m
- $420.55m
- $126.08m
- 71
- 34
- 70
- 60
Annual income statement for SurModics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 94.9 | 105 | 100 | 133 | 126 |
| Cost of Revenue | |||||
| Gross Profit | 79.5 | 88.5 | 79.6 | 108 | 93.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 96.1 | 98.4 | 122 | 127 | 132 |
| Operating Profit | -1.25 | 6.7 | -22.1 | 5.15 | -5.64 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.45 | 6.35 | -22.5 | 2.49 | -7.51 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.12 | 4.24 | -27.3 | -1.54 | -11.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.12 | 4.24 | -27.3 | -1.54 | -11.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.12 | 4.24 | -27.3 | -1.54 | -11.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.081 | 0.525 | -1.96 | -0.05 | -0.646 |